Pharmaceutical Sciences

Pharmaceutical Sciences Experts

Robert A. Sandhaus

Executive Vice President
Abeona Therapeutics
United States of America


 Robert A. Sandhaus, MD, PhD, FCCP serves as an Executive Vice President and Medical Director at AlphaNet, Inc. Dr. Sandhaus is the Founder of AlphaNet. Dr. Sandhaus is a Professor of Medicine, National Jewish Health at University of Colorado, Denver, CO. He serves as Medical Director of the Alpha-1 Foundation. He serves as Clinical Director of Alpha-1 Foundation. He is an extensive pharma industry expert in pathogenesis of emphysema. He has extensive plasma therapeutics industry experience. He serves as a Director of The Alpha-1 Project, Inc. He serves as a Director of Alpha-1 Program of National Jewish Medical and Research Center, Denver, CO. He serves as Co-Director of University of Colorado Center for Genetic Lung Disease, Denver, CO. He serves as a Director of AlphaNet, Inc. He has been a Member of Scientific Advisory Board at Arriva Pharmaceuticals, Inc. since January 14, 2009. In addition to his ongoing academic career, he worked for a decade in research and development in the biopharmaceutical industry, running clinical development programs at Cortech, NeXstar Pharmaceuticals, and Gilead Sciences. He is an expert in the pathogenesis of emphysema. Dr. Sandhaus completed his Internship of Internal Medicine from Harvard Medical School, Boston, MA. He is a Fellow of Pulmonary and Critical Care Medicine at University of California, San Francisco. He received his bachelor degree in molecular biology from Haverford College. He earned MD and PhD from Stony Brook University, Stony Brook, New York.

Research Interest

 Biopharmaceutical industry

Global Experts from United States of America

Global Experts in Subject

Share This Profile